New technique finding drugs fight malaria

New technique for finding drugs to fight malaria

5:59 AM, 12th February 2015
New technique for finding drugs to fight malaria
Myles Akabas, Professor, Albert Einstein College of Medicine.

BRONX, US: Each year nearly 600,000 people - mostly children under age five and pregnant women in sub-Saharan Africa - die from malaria, caused by single-celled parasites that grow inside red blood cells. The most deadly malarial species -Plasmodium falciparum - has proven notoriously resistant to treatment efforts. But thanks to a novel approach developed by scientists at Albert Einstein College of Medicine of Yeshiva University and described in the online edition of ACS Chemical Biology, researchers can readily screen thousands of drugs to find those potentially able to kill P. falciparum.

Scientists have known for more than a decade that malaria parasites have an Achilles heel: Like all cells, they require two key building blocks - purines and pyrimidines - to synthesize their DNA and RNA. But malaria parasites can’t synthesize purines on their own. Instead, they must import purines from the host red blood cells that they invade. A parasite protein called PfENT1 transports purines from blood cell into the parasites. So drugs that block PfENT1 could conceivably kill the parasites by depriving them of purines they need - but an experimental approach for identifying PfENT1 inhibitors didn’t exist, until now.

Einstein’s Myles Akabas, M.D., Ph.D., developed a novel yeast-based high-throughput assay for identifying inhibitors of the PfENT1 transporter. Dr Akabas worked with two MSTP students in his lab (I.J. Frame and Roman Deniskin) as well as colleagues at Einstein (Drs. Ian Willis and Robyn Moir) and Columbia University (Drs. Donald Landry and David Fidock). The researchers used their technique to screen 64,560 different compounds. They identified 171 potential antimalarial drugs. Studies of nine of the most potent drugs showed that they kill P. falciparum parasites in laboratory culture. “We’ve shown that the PfENT1 transporter is a potential drug target for developing novel antimalarial drugs. By using our rather simple approach, scientists could create similar high-throughput screens to identify inhibitors for killing other parasites that rely on transporters to import essential nutrients,” said Dr Akabas, senior author of the ACS Chemical Biology paper and a professor of physiology & biophysics, of medicine and in the Dominick P. Purpura Department of Neuroscience at Einstein.


© Albert Einstein College of Medicine News 



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Uralchem, Stamicarbon JV for urea production modernization in Perm, Russia

MOSCOW, RUSSIA: Uralchem OJSC, a leading manufacturer of nitrogen fertilizers, and Stamicarbon BV, a world leader in the area of development and licen ...

Read more
New non-stick material may help prevents bacterial infection

BOSTON, US: More than 80 per cent of microbial infections in the human body are caused by a build–up of bacteria, according to the National Inst ...

Read more
Making better wound dressing with fish skin

WASHINGTON DC, US: Researchers say that tilapia, the dinnertime fish for many Americans, could help to heal wounds. In the journal ACS Applied Materia ...

Read more
Kinder Morgan to buy Vopak’s three terminals, one undeveloped site

HOUSTON, US: Kinder Morgan, Inc (KMI) announced that it will purchase three terminals and one undeveloped site from Royal Vopak for approximately $158 ...

Read more
Bionic leaf converts solar energy into liquid fuel using bacteria

MASSACHUSETTS, US: Harvesting sunlight is a trick plants mastered more than a billion years ago, using solar energy to feed themselves from the air an ...

Read more
Air Liquide to supply oxygen to methanol plant in Louisiana, US

LOUISIANA, US: Air Liquide has been selected by the Chinese petrochemical company Yuhuang Chemical, Inc to provide oxygen to its new methanol producti ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X